Furthermore, in a year-long trial on postmenopausal women with osteopenia, Pingali and Nutalapati [19] showed that Shilajit preserved bone mineral density and favorably modulated bone turnover markers (decreased CTX-1 and RANKL, increased OPG), alongside reductions in oxidative stress and inflammatory markers. Here, TNFSF11 is linked to Osteopenia.